Morning Ireland podkast

Immunising infants and older people against RSV found to not be cost-effective - HIQA

28.04.2026
0:00
2:54
Do tyłu o 15 sekund
Do przodu o 15 sekund
Dr. Máirín Ryan, HIQA Director of Health Technology Assessment, explains its assessment of immunisation programmes against RSV.

See omnystudio.com/listener for privacy information.

Więcej odcinków z kanału "Morning Ireland"